Cargando…
Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green
BACKGROUND: Minimally invasive esophagectomy with two-field lymphadenectomy is standard of care for T1b esophageal adenocarcinoma (EAC) with a high risk of lymph node metastasis. Sentinel node navigation surgery (SNNS) is a well-known concept to tailor the extent of lymphadenectomy. The aim of this...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921120/ https://www.ncbi.nlm.nih.gov/pubmed/34046715 http://dx.doi.org/10.1007/s00464-021-08551-6 |
_version_ | 1784669268961394688 |
---|---|
author | Overwater, Anouk Weusten, Bas L. A. M. Ruurda, Jelle P. van Hillegersberg, Richard Bennink, Roel J. de Keizer, Bart Meijer, Sybren L. Brosens, Lodewijk A. A. Pouw, Roos E. Bergman, Jacques J. G. H. M. van Berge Henegouwen, Mark I. Gisbertz, Suzanne S. |
author_facet | Overwater, Anouk Weusten, Bas L. A. M. Ruurda, Jelle P. van Hillegersberg, Richard Bennink, Roel J. de Keizer, Bart Meijer, Sybren L. Brosens, Lodewijk A. A. Pouw, Roos E. Bergman, Jacques J. G. H. M. van Berge Henegouwen, Mark I. Gisbertz, Suzanne S. |
author_sort | Overwater, Anouk |
collection | PubMed |
description | BACKGROUND: Minimally invasive esophagectomy with two-field lymphadenectomy is standard of care for T1b esophageal adenocarcinoma (EAC) with a high risk of lymph node metastasis. Sentinel node navigation surgery (SNNS) is a well-known concept to tailor the extent of lymphadenectomy. The aim of this study was to evaluate the feasibility and safety of SNNS with a hybrid tracer (technetium-99 m/indocyanine green/nanocolloid) for patients with high-risk T1b EAC. METHODS: In this prospective, multicenter pilot study, 5 patients with high-risk T1b EAC were included. The tracer was injected endoscopically around the endoscopic resection scar the day before surgery, followed by preoperative imaging (lymphoscintigraphy/SPECT-CT). During surgery, first the SNs were localized and resected based on preoperative imaging and intraoperative gammaprobe- and fluorescence-based detection, followed by esophagectomy. Primary endpoints were the percentage of patients with detectable SNs, concordance between preoperative and intraoperative SN detection, and the additive value of indocyanine green. RESULTS: SNs could be identified and resected in all patients (median 3 SNs per patient, range 2–7). There was a high concordance between preoperative and intraoperative SN detection. In 2 patients additional peritumoral SNs were identified with fluorescence-based detection. None of the resected lymph nodes showed signs of (micro)metastases and no nodal metastases were detected in the surgical resection specimen. CONCLUSIONS: SNNS using technetium-99 m/indocyanine green/nanocolloid seems feasible and safe in patients with high-risk T1b EAC. Indocyanine green fluorescence seems to be of additive value for detection of peritumoral SNs. Whether this approach can optimize selection for esophagectomy needs to be studied in future research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-021-08551-6. |
format | Online Article Text |
id | pubmed-8921120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-89211202022-03-17 Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green Overwater, Anouk Weusten, Bas L. A. M. Ruurda, Jelle P. van Hillegersberg, Richard Bennink, Roel J. de Keizer, Bart Meijer, Sybren L. Brosens, Lodewijk A. A. Pouw, Roos E. Bergman, Jacques J. G. H. M. van Berge Henegouwen, Mark I. Gisbertz, Suzanne S. Surg Endosc Commentary BACKGROUND: Minimally invasive esophagectomy with two-field lymphadenectomy is standard of care for T1b esophageal adenocarcinoma (EAC) with a high risk of lymph node metastasis. Sentinel node navigation surgery (SNNS) is a well-known concept to tailor the extent of lymphadenectomy. The aim of this study was to evaluate the feasibility and safety of SNNS with a hybrid tracer (technetium-99 m/indocyanine green/nanocolloid) for patients with high-risk T1b EAC. METHODS: In this prospective, multicenter pilot study, 5 patients with high-risk T1b EAC were included. The tracer was injected endoscopically around the endoscopic resection scar the day before surgery, followed by preoperative imaging (lymphoscintigraphy/SPECT-CT). During surgery, first the SNs were localized and resected based on preoperative imaging and intraoperative gammaprobe- and fluorescence-based detection, followed by esophagectomy. Primary endpoints were the percentage of patients with detectable SNs, concordance between preoperative and intraoperative SN detection, and the additive value of indocyanine green. RESULTS: SNs could be identified and resected in all patients (median 3 SNs per patient, range 2–7). There was a high concordance between preoperative and intraoperative SN detection. In 2 patients additional peritumoral SNs were identified with fluorescence-based detection. None of the resected lymph nodes showed signs of (micro)metastases and no nodal metastases were detected in the surgical resection specimen. CONCLUSIONS: SNNS using technetium-99 m/indocyanine green/nanocolloid seems feasible and safe in patients with high-risk T1b EAC. Indocyanine green fluorescence seems to be of additive value for detection of peritumoral SNs. Whether this approach can optimize selection for esophagectomy needs to be studied in future research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-021-08551-6. Springer US 2021-05-27 2022 /pmc/articles/PMC8921120/ /pubmed/34046715 http://dx.doi.org/10.1007/s00464-021-08551-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Commentary Overwater, Anouk Weusten, Bas L. A. M. Ruurda, Jelle P. van Hillegersberg, Richard Bennink, Roel J. de Keizer, Bart Meijer, Sybren L. Brosens, Lodewijk A. A. Pouw, Roos E. Bergman, Jacques J. G. H. M. van Berge Henegouwen, Mark I. Gisbertz, Suzanne S. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green |
title | Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green |
title_full | Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green |
title_fullStr | Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green |
title_full_unstemmed | Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green |
title_short | Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green |
title_sort | feasibility of sentinel node navigated surgery in high-risk t1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921120/ https://www.ncbi.nlm.nih.gov/pubmed/34046715 http://dx.doi.org/10.1007/s00464-021-08551-6 |
work_keys_str_mv | AT overwateranouk feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT weustenbaslam feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT ruurdajellep feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT vanhillegersbergrichard feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT benninkroelj feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT dekeizerbart feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT meijersybrenl feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT brosenslodewijkaa feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT pouwroose feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT bergmanjacquesjghm feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT vanbergehenegouwenmarki feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen AT gisbertzsuzannes feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen |